Prognostic role of serum sodium levels across different serum potassium levels in heart failure patients: A Danish register-based cohort study

International Journal of Cardiology

Volumn 272, Issue , 2018, Pages 244-249

  Polcwiartek, Christoffer ^a,b   Hansen, Steen Møller ^a   Kragholm, Kristian ^a,c   Krogager, Maria Lukács ^a   Aldahl, Mette ^a   Køber, Lars ^d   Torp Pedersen, Christian ^a,b   Jensen, Svend Eggert ^a,b   Søgaard, Peter ^a,b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

^c NORTH DENMARK REGIONAL HOSPITAL   (Denmark)

^d University of Copenhagen   (Denmark)

Author keywords

Diuretics; Electrolyte disturbances; Heart failure; Potassium; Sodium

Indexed keywords

LOOP DIURETIC AGENT; POTASSIUM; SODIUM; BIOLOGICAL MARKER;

AGED; ALL CAUSE MORTALITY; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPOKALEMIA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; OUTCOME ASSESSMENT; POPULATION RESEARCH; POTASSIUM BLOOD LEVEL; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SODIUM BLOOD LEVEL; VERY ELDERLY; BLOOD; DENMARK; EPIDEMIOLOGY; MORTALITY; REGISTER; TRENDS;

AGED; AGED, 80 AND OVER; BIOMARKERS; COHORT STUDIES; DENMARK; FEMALE; HEART FAILURE; HUMANS; MALE; MORTALITY; POTASSIUM; PROGNOSIS; REGISTRIES; SODIUM;

EID: 85051749248     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2018.08.045     Document Type: Article

References (31)

1. Urso, C., Brucculeri, S., Caimi, G., Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail. Rev. 20:4 (2015), 493–503.
2. Verbrugge, F.H., et al. Hyponatremia in acute decompensated heart failure: depletion versus dilution. J. Am. Coll. Cardiol. 65:5 (2015), 480–492.
3. Krogager, M.L., et al. Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data. Eur. Heart J. 38:2 (2017), 104–112.
4. Collins, A.J., et al. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am. J. Nephrol. 46:3 (2017), 213–221.
5. Aldahl, M., et al. Associations of serum potassium levels with mortality in chronic heart failure patients. Eur. Heart J. 38:38 (2017), 2890–2896.
6. Krogager, M.L., et al. Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction. Eur. Heart J. Cardiovasc. Pharmacother. 1:4 (2015), 245–251.
7. Kovesdy, C.P., et al. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 125:5 (2012), 677–684.
8. Deubner, N., et al. Dysnatraemia in heart failure. Eur. J. Heart Fail. 14:10 (2012), 1147–1154.
9. Mohammed, A.A., et al. Hyponatremia, natriuretic peptides, and outcomes in acutely decompensated heart failure: results from the International Collaborative of NT-proBNP Study. Circ. Heart Fail. 3:3 (2010), 354–361.
10. Gheorghiade, M., et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur. Heart J. 28:8 (2007), 980–988.
11. Pitt, B., Rossignol, P., Serum potassium in patients with chronic heart failure: once we make a U-turn where should we go?. Eur. Heart J. 38:38 (2017), 2897–2899.
12. Pitt, B., Rossignol, P., The association between serum potassium and mortality in patients with hypertension: ‘a wake-up call’. Eur. Heart J. 38:2 (2017), 113–115.
13. Ghali, J.K., Shah, A.I., Defining hyponatraemia: a call for action. Eur. J. Heart Fail. 14:10 (2012), 1085–1086.
14. Ghali, J.K., Hyponatraemia in heart failure: a call for redefinition. Eur. Heart J. 28:8 (2007), 920–921.
15. Lynge, E., Sandegaard, J.L., Rebolj, M., The Danish National Patient Register. Scand. J. Public Health 39:7 Suppl (2011), 30–33.
16. Kümler, T., et al. Accuracy of a heart failure diagnosis in administrative registers. Eur. J. Heart Fail. 10:7 (2008), 658–660.
17. Kildemoes, H.W., Sørensen, H.T., Hallas, J., The Danish National Prescription Registry. Scand. J. Public Health 39:7 Suppl (2011), 38–41.
18. Pedersen, C.B., The Danish Civil Registration System. Scand. J. Public Health 39:7 Suppl (2011), 22–25.
19. Helweg-Larsen, K., The Danish Register of Causes of Death. Scand. J. Public Health 39:7 Suppl (2011), 26–29.
20. Overgaard-Steensen, C., Ring, T., Clinical review: practical approach to hyponatraemia and hypernatraemia in critically ill patients. Crit. Care, 17(1), 2013, 206.
21. Carlsson, L., Lind, L., Larsson, A., Reference values for 27 clinical chemistry tests in 70-year-old males and females. Gerontology 56:3 (2010), 259–265.
22. Rustad, P., et al. The Nordic Reference Interval Project 2000: recommended reference intervals for 25 common biochemical properties. Scand. J. Clin. Lab. Invest. 64:4 (2004), 271–284.
23. Mårtensson, A., et al. Creatininium reference intervals for corrected methods. Scand. J. Clin. Lab. Invest. 64:4 (2004), 439–441.
24. Levey, A.S., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150:9 (2009), 604–612.
25. Thomas, L., Reyes, E.M., Tutorial: survival estimation for Cox regression models with time-varying coefficients using SAS and R. J. Stat. Softw. 61:1 (2014), 1–23.
26. Corona, G., et al. Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One, 8(12), 2013, e80451.
27. Rusinaru, D., et al. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(dagger): Meta-Analysis Global Group in Chronic heart failure (MAGGIC). Eur. J. Heart Fail. 14:10 (2012), 1139–1146.
28. Chawla, A., et al. Mortality and serum sodium: do patients die from or with hyponatremia?. Clin. J. Am. Soc. Nephrol. 6:5 (2011), 960–965.
29. Konstam, M.A., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297:12 (2007), 1319–1331.
30. Sarwar, C.M., et al. Hyperkalemia in heart failure. J. Am. Coll. Cardiol. 68:14 (2016), 1575–1589.
31. Stavros, F., et al. Characterization of structure and function of ZS-9, a K+ selective ion trap. PLoS One, 9(12), 2014, e114686.